Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

NCT04500860 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence

Interventions

DRUG: Low dose tadalafil 5 mg
DRUG: Tolterodine 4 Mg Oral Capsule, Extended Release
DRUG: Placebo

Sponsor

Kasr El Aini Hospital